ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ABIO ARCA Biopharma Inc

3.58
0.10 (2.87%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ARCA Biopharma Inc ABIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.10 2.87% 3.58 18:24:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.68 3.5001 3.68 3.58 3.48
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202415:15GLOBEARCA biopharma Announces First Quarter 2024 Financial..
05/4/202412:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202406:30GLOBEARCA biopharma and Oruka Therapeutics Announce Merger..
07/2/202412:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202415:15EDGAR2Form 8-K - Current report
01/2/202415:39EDGAR2Form 8-K - Current report
01/2/202415:35GLOBEARCA biopharma Announces 2023 Financial Results
01/2/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
31/1/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:15EDGAR2Form 8-K - Current report
19/12/202315:25EDGAR2Form ARS - Annual Report to Security Holders
19/12/202315:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202315:15EDGAR2Form DEF 14A - Other definitive proxy statements
05/12/202315:25EDGAR2Form 8-K - Current report
04/12/202315:36EDGAR2Form 8-K - Current report
18/10/202315:35EDGAR2Form 8-K - Current report
18/10/202315:25GLOBEARCA biopharma Announces Third Quarter 2023 Financial..
18/10/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/9/202315:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/7/202315:35EDGAR2Form 8-K - Current report
21/7/202315:25GLOBEARCA biopharma Announces Second Quarter 2023 Financial..
21/7/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

Delayed Upgrade Clock